Sign in
4

Changes in Ownership

CRISPR Therapeutics AG Filed Acc 0000950170-23-053817

Options or other derivatives

  • General Counsel and Secretary acquired 23,007 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
KASINGER JAMES R. General Counsel and Secretary 2023-10-13 Grant or award · Stock Option (Right to Buy) +16,667 16,667 D: show line 1 in the form
KASINGER JAMES R. General Counsel and Secretary 2023-10-13 Grant or award · Restricted Stock Units +6,340 6,340 D: show line 2 in the form
Loading xslF345X05/ownership.xml…